SUBOXONE cpr subling 8/2 mg 7 pce
7680584050078
CH-58405
N07BC51
01.01.3.
1 / 3
google
Details
- Product number
- 5840502
- CPT
- -
- Packaging group
- 7
- Unit
- Tablette(n)
- Composition
- buprenorphinum 8 mg ut buprenorphini hydrochloridum, naloxonum 2 mg ut naloxoni hydrochloridum dihydricum, lactosum monohydricum corresp. lactosum 167.5 mg, mannitolum, maydis amylum, povidonum K 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.24 mg, aromatica (Zitrone und Limette) cum linaloolum et citralum et E 320, acesulfamum kalicum, magnesii stearas, pro compresso.
Articles (1)
Suboxone 8 mg/2 mg, Sublingualtabletten
Sublingualtabletten
7
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
buprenorphinum
|
8.0 MG | Substance | Wirkstoff (Principe actif) |
|
buprenorphini hydrochloridum
|
- | Substance | WIZUS |
|
naloxonum
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
naloxoni hydrochloridum dihydricum
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
- | Substance | HNIDK |
|
lactosum
|
167.5 MG | Substance | HBESI |
|
mannitolum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
acidum citricum
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrium
|
0.24 MG | Substance | HBESI |
|
aromatica
|
- | Substance | AROMA |
|
linaloolum
|
- | Substance | HBESI |
|
citralum
|
- | Substance | HBESI |
|
E 320
|
- | Substance | HBESI |
|
acesulfamum kalicum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Indivior Schweiz AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 58405
- Drug name
- Suboxone, Sublingualtabletten
- Galenic form
- SUBL
- ATC Code
- N07BC51
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A+
- First authorization
- 25/02/2009
- Authorization expiration date
- 23/10/2025
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SUBOXONE cpr subling 8/2 mg 7 pce
- Description (DE)
- SUBOXONE Subling Tabl 8/2 mg 7 Stk
- Market launch
- 25/02/2009
- Market withdrawal
- 24/10/2025
- Narcotic (BTM)
- A